CBIO
Crescent Biopharma
CBIO
CBIO
30 hedge funds and large institutions have $174M invested in Crescent Biopharma in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$29.9M | |
| 2 | +$29.4M | |
| 3 | +$28.7M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$27.3M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$13.6M |
Top Sellers
| 1 | -$561K | |
| 2 | -$120K | |
| 3 | -$93.8K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$80.3K |
| 5 |
SC
Shay Capital
New York
|
-$74.9K |